Relypsa develops polymeric drugs for cardiovascular, metabolic and renal diseases.
$80M
Aug 14, 2012
-
Relypsa develops polymeric drugs for cardiovascular, metabolic and renal diseases.
$70M
Sep 13, 2010
-
Relypsa develops polymeric drugs for cardiovascular, metabolic and renal diseases.
$33M
Oct 28, 2007
-
PatientKeeper is a Massachusetts-based cloud platform that offers solutions
such as EHR optimization and medication reconciliation for the healthcare industry.
$8M
Jun 12, 2006
-
Frequently Asked Questions about Mediphase Venture Partners
What is Mediphase Venture Partners investing in?
Mediphase Venture Partners has invested in 4 companies including Relypsa, Relypsa and Relypsa
What company did Mediphase Venture Partners invest in?
Mediphase Venture Partners invested in a total 4 companies including Relypsa, Relypsa and Relypsa
What are the top 4 investments by Mediphase Venture Partners?
The top companies in which Mediphase Venture Partners invested are Relypsa, Relypsa, Relypsa and PatientKeeper